Sector revisions Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
Equities
600329
CNE000001808
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.06 CNY | -1.18% |
|
-0.29% | -10.00% |
| Mar. 31 | Tianjin Pharmaceutical Da Ren Tang's Attributable Profit Drops 4.4% in 2025 | MT |
| Mar. 31 | Singapore Shares Remain in Red Amid Soaring Energy Costs; Rex International Plunges 20% | MT |
Main competitors
| 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Visibility | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|
 | - | - | ||||||
| 10 | |||||||
| 6 | |||||||
| 10 | |||||||
| 2 | |||||||
| - | - | ||||||
| 4 | |||||||
| - | 1 | ||||||
| - | - | ||||||
| - | - | ||||||
| - | - | ||||||
| 4 | |||||||
| 11 | |||||||
| Average | 6 | |||||||
| Weighted average by Cap. | 7 |
Select your edition
All financial news and data tailored to specific country editions
